What is a Dupixent lawsuit?

A Dupixent lawsuit is a legal claim alleging that the prescription medication caused or contributed to a patient's injuries.Current product liability lawsuits focus primarily on patients who developed CTCL or certain other T-cell lymphomas after receiving Dupixent.These lawsuits allege that the medication's manufacturers, Sanofi and Regeneron, failed to adequately warn patients and healthcare providers about potential lymphoma-related risks.

Does Dupixent cause T-cell lymphoma?

Researchers have identified an association between Dupixent use and CTCL diagnoses in some studies. However, a direct causal relationship has not been established.One challenge is that early CTCL can resemble eczema, the condition Dupixent is frequently prescribed to treat. Some patients may have had undiagnosed lymphoma before beginning treatment.Lawsuits allege that Dupixent may cause, accelerate, or mask CTCL in certain patients. These allegations remain subject to scientific investigation and legal proceedings.

What are the symptoms of cutaneous T-cell lymphoma?

CTCL symptoms can vary depending on the type and stage of the disease. Common symptoms may include persistent itching, red or scaly patches, thickened skin, and raised plaques.Some patients may develop skin tumors, swollen lymph nodes, widespread skin redness, or other complications as the disease progresses.Because these symptoms can resemble eczema or other inflammatory skin conditions, an accurate diagnosis may require skin biopsies, blood testing, and specialized medical evaluation.

What should I do if I develop lymphoma after taking Dupixent?

If you have been diagnosed with lymphoma after receiving Dupixent, follow your healthcare provider's recommendations for treatment and ongoing monitoring.You may also want to preserve records of your Dupixent prescriptions, medical appointments, skin symptoms, biopsy results, and cancer diagnosis.An attorney can review these records and help determine whether your circumstances may support a product liability claim.Do not stop taking or change a prescribed medication without consulting your healthcare provider.

Is there a class action lawsuit against Dupixent?

Federal Dupixent product liability lawsuits involving CTCL were consolidated into multidistrict litigation, or MDL, in June 2026.An MDL allows lawsuits involving similar allegations to be coordinated before one federal judge for certain pretrial proceedings.Unlike a traditional class action, plaintiffs in an MDL generally maintain individual claims. The outcome of each case may depend on factors such as medical history, the nature of the lymphoma diagnosis, and the extent of the injuries.

How long do I have to file a Dupixent lawsuit?

The deadline for filing a Dupixent lawsuit depends on the applicable state law, the nature of the claim, and the circumstances surrounding the diagnosis.Some deadlines may be affected by when an injury was discovered or when a patient reasonably could have learned of a potential connection between the injury and a medication.Because missing an applicable deadline can prevent you from pursuing compensation, it is important to consult an attorney as soon as possible.

Why should I choose Morgan & Morgan for my Dupixent lawsuit?

Prescription drug lawsuits can involve complex medical research, extensive treatment records, and disputes over whether a medication caused or contributed to a serious illness.As America’s Largest Injury Law Firm™, with more than [ftp_global_var:attorney_count] lawyers nationwide, $[ftp_global_var:total_funds_recovered_count] billion recovered, and [ftp_global_var:years] years of experience, Morgan & Morgan has the resources to investigate complex product liability claims and pursue compensation from responsible parties.Our attorneys can review prescription histories, evaluate medical evidence, consult qualified experts, and help patients and families understand their legal options.We believe everyone deserves access to excellent legal representation, regardless of their financial situation. That's why we offer free case evaluations, and with our contingency fee arrangement, you don't pay attorney's fees unless we win your case. The Fee is Free®.Take our free case evaluation today to learn how we may be able to help.

“The Fee is Free unless you win.”

Dan Morgan Managing Partner

Play Video

Can I Sue for Developing Lymphoma After Taking Dupixent?

Dupixent is a prescription medication used to treat eczema, asthma, and other inflammatory conditions. However, concerns have emerged about a possible connection between Dupixent and cutaneous T-cell lymphoma, a rare form of cancer. If you or a loved one developed T-cell lymphoma after taking Dupixent, you may have legal options. Morgan & Morgan can help you explore your rights. Take our free case evaluation today.

See if you qualify

The attorney shown above may not be licensed in your state. To find an attorney licensed in your area, please visit our attorney page.

“The Fee is Free unless you win.”

Dan Morgan Managing Partner

Play Video

The attorney shown above may not be licensed in your state. To find an attorney licensed in your area, please visit our attorney page.

Start your claim

Meet Our Dupixent Lawsuit Lawyers

Morgan & Morgan’s product liability attorneys have experience investigating claims involving dangerous drugs like Dupixent, including reviewing prescription histories, medical records, and symptom timelines to evaluate whether the medication may have contributed to a patient’s injuries. Backed by the resources of America’s Largest Injury Law Firm™, our attorneys can work with medical experts, take on major pharmaceutical companies, and fight for patients and families harmed by allegedly dangerous medications.

The attorneys shown in these photos may not be licensed in your state. To find an attorney licensed in your area, please visit our attorney page.

What Is the Dupixent Lymphoma Risk?

Dupixent (dupilumab) is an injectable prescription medication manufactured by Sanofi and Regeneron Pharmaceuticals. It is used to treat several inflammatory conditions, including moderate-to-severe atopic dermatitis, commonly known as eczema, and certain types of asthma.

The medication works by blocking specific proteins involved in the body's inflammatory response. While Dupixent has helped many patients manage chronic conditions, concerns have emerged about a potential association between the drug and cutaneous T-cell lymphoma (CTCL).

CTCL is a rare form of non-Hodgkin lymphoma that affects T cells, a type of white blood cell involved in the immune system. The disease primarily affects the skin and may initially resemble eczema, causing redness, itching, scaly patches, and other symptoms.

Some patients treated with Dupixent have subsequently been diagnosed with CTCL, raising questions about whether the medication may contribute to the development or progression of the disease or delay recognition of an existing lymphoma.

Researchers continue to investigate this potential connection. Although some studies have identified an association between Dupixent use and CTCL diagnoses, that association does not establish that the medication causes lymphoma.

Patients who received Dupixent and were later diagnosed with CTCL or another T-cell lymphoma may be exploring whether the drug's manufacturers adequately disclosed potential safety concerns.

Get your free consultation today.

700,000+ clients Chose Morgan & Morgan Nationwide.
$0 upfront Only pay if we win.
Available 24/7 Get help anytime.

Dupixent Lawsuits at a Glance

Dupixent Exposure

Dupixent is prescribed for eczema, asthma, and several other inflammatory conditions. Some patients who received the medication have subsequently been diagnosed with CTCL or other forms of T-cell lymphoma.

Alleged Failure to Warn

Lawsuits allege that Sanofi and Regeneron failed to provide adequate warnings about the potential for Dupixent to cause, accelerate, or mask T-cell lymphoma, potentially delaying appropriate testing and treatment.

Serious Cancer Diagnoses

CTCL can cause persistent skin symptoms and, in advanced cases, affect lymph nodes, blood, and internal organs. Patients may require chemotherapy, radiation, immunotherapy, or other cancer treatments.

Do I Have a Case?

A History of Dupixent Use

Patients who received Dupixent to treat eczema, asthma, or another approved condition may have grounds to investigate whether the medication contributed to a subsequent lymphoma diagnosis.

A T-Cell Lymphoma Diagnosis

A diagnosis of CTCL, mycosis fungoides, Sézary syndrome, or another T-cell lymphoma following Dupixent treatment may be an important part of evaluating a potential claim.

Evidence Connecting the Diagnosis to Treatment

Prescription records, medical histories, skin biopsies, pathology reports, and the timing of symptoms may help determine whether Dupixent could have contributed to the development, progression, or delayed recognition of lymphoma.

In Their Words

Real clients share their experience.

When it came to negotiating, they didn't just settle for anything. They definitely went to the bat for me.

Lashondra

They took care of me, and now we're doing okay. Thank God that I went to Morgan & Morgan.

Ray

The company handled absolutely everything from start to finish.

Sean

Lashondra

Ray

Sean

Results may vary depending on your particular facts and legal circumstances.
Based on select nationwide reviews.

Why This Risk Matters

CTCL can be difficult to recognize because its early symptoms frequently resemble eczema and other common inflammatory skin conditions.

Patients may experience persistent itching, redness, rashes, and scaly patches for months or years before receiving an accurate cancer diagnosis.

Because Dupixent is commonly prescribed to treat moderate-to-severe eczema, some patients who have an undiagnosed form of CTCL may receive the medication for what initially appears to be an inflammatory skin condition. This overlap has raised concerns about whether Dupixent could affect the progression of an existing lymphoma or delay diagnosis by temporarily improving symptoms that resemble eczema.

Delayed recognition of CTCL can be particularly concerning because some forms of the disease may progress beyond the skin and require more intensive treatment.

Medical Research and Dupixent Safety Concerns

Medical researchers have investigated whether Dupixent use is associated with an increased likelihood of CTCL diagnoses.

A 2024 study published in the Journal of the American Academy of Dermatology found an increased rate of CTCL diagnoses among patients with atopic dermatitis who received dupilumab compared with patients who did not.

Additional research has examined whether Dupixent may be associated with the development, unmasking, or progression of CTCL.

However, the relationship remains under investigation. CTCL itself can initially resemble eczema, making it difficult to determine whether the medication contributed to the disease or whether an existing lymphoma was mistaken for the condition Dupixent was prescribed to treat.

These concerns have become central to lawsuits alleging that patients and healthcare providers were not adequately informed about potential lymphoma-related risks.

Fighting For the People

Backed by America’s Largest Injury Law Firm.

$35 Billion
Recovered for clients
nationwide
700,000+
Clients and families
served
1,100+
Attorneys across
the country
1
Click may change your life

Your case isn't just another file to us. It's your life, your future, and your family. And we take that personally.

Dan Morgan

Managing Partner, Morgan & Morgan

Read Bio

The attorney featured above is licensed in Florida. For a full list of attorneys in your state please visit our attorney page.
Results may vary depending on your particular facts and legal circumstances.

The Fee is Free®

Only pay if we win.
Contact us 24/7.

It's Easy to Get Started

Provide a few simple details about your injury and our team will take it from there.

By submitting this form, you agree to our Terms & acknowledge our privacy policy.

By submitting my phone number above I authorize Morgan & Morgan, and its service providers, to deliver calls including using an automatic telephone dialing system or artificial or prerecorded voice, to the number submitted. Consent is not a condition to receive services. Msg frequency varies. Msg & data rates may apply. Upon receipt of any message, reply STOP to unsubscribe.

Ways We Can Help

Medical Expenses

Compensation may help cover cancer screenings, biopsies, specialist appointments, chemotherapy, radiation, medications, hospitalization, and other medical expenses associated with lymphoma.

Lost Income

Cancer treatment and recovery may require patients to take extended time away from work or leave their jobs entirely.

Pain and Suffering

A claim may seek compensation for physical pain, persistent skin symptoms, emotional distress, and other effects of a serious cancer diagnosis.

Future Medical Care

Patients with CTCL may require ongoing cancer treatment, monitoring, specialized medications, or other long-term medical services.

Loss of Earning Capacity

If lymphoma or complications from treatment permanently affect a patient's ability to work, compensation may account for reduced future income and employment opportunities.

Wrongful Death

When a patient dies from lymphoma allegedly caused or worsened by a dangerous medication, eligible surviving family members or representatives may have grounds to pursue a wrongful death claim.

Potential Dupixent-Related Lymphoma Diagnoses and Complications

Cutaneous T-Cell Lymphoma (CTCL)

CTCL is a group of rare non-Hodgkin lymphomas that primarily affect the skin. Symptoms may include persistent itching, redness, scaly patches, plaques, and skin tumors. Advanced disease may spread beyond the skin.

Mycosis Fungoides

Mycosis fungoides is the most common form of CTCL. It often develops slowly and can initially resemble eczema or psoriasis, making early diagnosis challenging.

Sézary Syndrome

Sézary syndrome is a rare and aggressive form of CTCL that affects the skin, blood, and often lymph nodes. Patients may experience widespread redness, severe itching, and other serious complications.

Peripheral T-Cell Lymphoma

Peripheral T-cell lymphoma refers to a group of uncommon non-Hodgkin lymphomas involving mature T cells. Certain Dupixent lawsuits have raised concerns about T-cell lymphomas beyond CTCL, although the evidence and potential connection may differ by diagnosis.

Delayed Cancer Diagnosis

Because early CTCL symptoms may resemble eczema, patients can experience delays in receiving an accurate diagnosis. Lawsuits allege that Dupixent may have masked or affected symptoms in some patients, potentially contributing to delayed recognition of the disease.

Disease Progression and Long-Term Complications

Advanced CTCL may affect lymph nodes, blood, and internal organs. Some patients require intensive treatment and may experience serious complications, lasting health limitations, or reduced quality of life.

FAQ

Reviewed by Michael Goetz, Attorney at Morgan & Morgan, on October 15, 2026.

What is a Dupixent lawsuit?
A Dupixent lawsuit is a legal claim alleging that the prescription medication caused or contributed to a patient's injuries.
Current product liability lawsuits focus primarily on patients who developed CTCL or certain other T-cell lymphomas after receiving Dupixent.
These lawsuits allege that the medication's manufacturers, Sanofi and Regeneron, failed to adequately warn patients and healthcare providers about potential lymphoma-related risks.
Does Dupixent cause T-cell lymphoma?
Researchers have identified an association between Dupixent use and CTCL diagnoses in some studies. However, a direct causal relationship has not been established.
One challenge is that early CTCL can resemble eczema, the condition Dupixent is frequently prescribed to treat. Some patients may have had undiagnosed lymphoma before beginning treatment.
Lawsuits allege that Dupixent may cause, accelerate, or mask CTCL in certain patients. These allegations remain subject to scientific investigation and legal proceedings.
What are the symptoms of cutaneous T-cell lymphoma?
CTCL symptoms can vary depending on the type and stage of the disease. Common symptoms may include persistent itching, red or scaly patches, thickened skin, and raised plaques.
Some patients may develop skin tumors, swollen lymph nodes, widespread skin redness, or other complications as the disease progresses.
Because these symptoms can resemble eczema or other inflammatory skin conditions, an accurate diagnosis may require skin biopsies, blood testing, and specialized medical evaluation.
What should I do if I develop lymphoma after taking Dupixent?
If you have been diagnosed with lymphoma after receiving Dupixent, follow your healthcare provider's recommendations for treatment and ongoing monitoring.
You may also want to preserve records of your Dupixent prescriptions, medical appointments, skin symptoms, biopsy results, and cancer diagnosis.
An attorney can review these records and help determine whether your circumstances may support a product liability claim.
Do not stop taking or change a prescribed medication without consulting your healthcare provider.
Is there a class action lawsuit against Dupixent?
Federal Dupixent product liability lawsuits involving CTCL were consolidated into multidistrict litigation, or MDL, in June 2026.
An MDL allows lawsuits involving similar allegations to be coordinated before one federal judge for certain pretrial proceedings.
Unlike a traditional class action, plaintiffs in an MDL generally maintain individual claims. The outcome of each case may depend on factors such as medical history, the nature of the lymphoma diagnosis, and the extent of the injuries.
How long do I have to file a Dupixent lawsuit?
The deadline for filing a Dupixent lawsuit depends on the applicable state law, the nature of the claim, and the circumstances surrounding the diagnosis.
Some deadlines may be affected by when an injury was discovered or when a patient reasonably could have learned of a potential connection between the injury and a medication.
Because missing an applicable deadline can prevent you from pursuing compensation, it is important to consult an attorney as soon as possible.
Why should I choose Morgan & Morgan for my Dupixent lawsuit?
Prescription drug lawsuits can involve complex medical research, extensive treatment records, and disputes over whether a medication caused or contributed to a serious illness.
As America’s Largest Injury Law Firm™, with more than 1,100 lawyers nationwide, $35 billion recovered, and 35 years of experience, Morgan & Morgan has the resources to investigate complex product liability claims and pursue compensation from responsible parties.
Our attorneys can review prescription histories, evaluate medical evidence, consult qualified experts, and help patients and families understand their legal options.
We believe everyone deserves access to excellent legal representation, regardless of their financial situation. That's why we offer free case evaluations, and with our contingency fee arrangement, you don't pay attorney's fees unless we win your case. The Fee is Free®.
Take our free case evaluation today to learn how we may be able to help.